ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Cash from operations

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 20259,566+11.78%
Dec 31, 20248,558+17.86%
Dec 31, 20237,261-24.21%
Dec 31, 20229,581-9.04%
Dec 31, 202110,533+33.31%
Dec 31, 20207,901+28.76%
Dec 31, 20196,136-2.60%
Dec 31, 20186,300+13.11%
Dec 31, 20175,570+73.90%
Dec 31, 20163,203+7.99%
Dec 31, 20152,966-10.77%
Dec 31, 20133,324-62.94%
Dec 31, 20118,970+2.68%
Dec 31, 20108,736

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat